Clinical Trial Update: The Vienna Prograf and Endothelial Progenitor Cell Study [Phase 4]

View source ↗

Summary

Phase 4 trial update from the Medical University of Vienna evaluating tacrolimus (Prograf) in combination with endothelial progenitor cells in end-stage renal d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Prograf (Tacrolimus)

Snippet

Sponsor: Medical University of Vienna | Conditions: End Stage Renal Disease | Phase 4 | Status: COMPLETED